Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase (TPI) deficiency.

A new interesting article has been published in J Inherit Metab Dis. 2019 May 20. doi: 10.1002/jimd.12105. and titled:

Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase (TPI) deficiency.

Authors of this article are:

Segal J, Mülleder M, Krüger A, Adler T, Scholze-Wittler M, Becker L, Calzada-Wack J, Garrett L, Hölter SM, Rathkolb B,, Rozman J,, Racz I, Fischer R, Busch DH, Neff F, Klingenspor M, Klopstock T,, Grüning NM, Michel S, Lukaszewska-McGreal B, Voigt I, Hartmann L, Timmermann B, Lehrach H, Wolf E, Wurst W,, Gailus-Durner V, Fuchs H, de Angelis MH,, Schrewe H, Yuneva M, Ralser M,.

A summary of the article is shown below:

Triosephosphate isomerase (TPI) deficiency is a fatal genetic disorder characterized by haemolytic anaemia and neurological dysfunction. Although the enzyme defect in TPI was discovered in the 1960s, the exact etiology of the disease is still debated. Some aspects indicate the disease could be caused by insufficient enzyme activity, whereas other observations indicate it could be a protein misfolding disease with tissue-specific differences in TPI activity. We generated a mouse model in which exchange of a conserved catalytic amino acid residue (isoleucine to valine, Ile170Val) reduces TPI specific activity without affecting the stability of the protein dimer. TPIIle170Val/Ile170Val mice exhibit an ~85% reduction in TPI activity consistently across all examined tissues, which is a stronger average activity decline than observed in patients or symptomatic mouse models that carry structural defect mutant alleles. While monitoring protein expression levels revealed no evidence for protein instability, metabolite quantification indicated that glycolysis is affected by the active site mutation. TPIIle170Val/Ile170Val mice develop normally and show none of the disease symptoms associated with TPI deficiency. Therefore, without the stability defect that penetrates in a tissue-specific manner, a strong decline in TPI catalytic activity is not sufficient to explain the pathological onset of TPI deficiency. This article is protected by copyright. All rights reserved.This article is protected by copyright. All rights reserved.

Check out the article’s website on Pubmed for more information:

This article is a good source of information and a good way to become familiar with topics such as: Active site mutation; Glycolytic enzymopathy; Haemolytic anaemia; Protein stability disorder; Site-directed mutagenesis; Triosephosphate isomerase deficiency.

Molecular Depot

Your specialty peptide, proteins, antibodies and chemical compounds store.